Market Overview

UPDATE: Morgan Stanley Initiates Coverage On Intuitive Surgical

Related ISRG
BTIG Likes What It Saw At Intuitive Surgical Conference
UPDATE: BTIG Upgrades Intuitive Surgical
Stocks Sell Off as Shift from Risk Persists (Fox Business)

In a report released Wednesday, Morgan Stanley analyst David Lewis initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with a base case of $370. Morgan Stanley previously had an Overweight rating.

Analysts at Morgan Stanley believe Intuitive Surgical's improved procedures will result in a short run investor relief rally, but they don't see proof of inflection. Lewis claimed Intuitive Surgical's ability to manage stock-comp is out of range compared to its peers.

Morgan Stanley is prevented from calling an inflection due to system utilization rates continuing to be in negative territory year-over-year. This indicates underlying demand for new systems, comps uncertainty from its recovery to decline and net system payments decline quarter-over-quarter.

Morgan Stanley's base case of $370 per share was given by a 25x multiple from its 2015 estimate of $14.78.

Latest Ratings for ISRG

DateFirmActionFromTo
Oct 2014Northland SecuritiesUpgradesUnderperformMarket Perform
Oct 2014BTIG ResearchUpgradesNeutralBuy
Oct 2014Leerink SwannUpgradesMarket PerformOutperform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: David Lewis Morgan StanleyAnalyst Color Initiation Analyst Ratings

 

Related Articles (ISRG)

Around the Web, We're Loving...

Get Benzinga's Newsletters